103502-48-3 Usage
General Description
Methyl 2-bromoquinoline-4-carboxylate is a chemical compound with the molecular formula C12H8BrNO2. It is a methyl ester derivative of 2-bromoquinoline-4-carboxylic acid, a heterocyclic aromatic compound. This chemical is commonly used in organic synthesis as a building block for a variety of pharmaceuticals, agrochemicals, and dyes. Methyl 2-bromoquinoline-4-carboxylate is a white to off-white crystalline solid that is sparingly soluble in water but soluble in organic solvents. It is important to handle this compound with care, as it may be harmful if ingested, inhaled, or absorbed through the skin, and it may cause irritation to the eyes and skin.
Check Digit Verification of cas no
The CAS Registry Mumber 103502-48-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,5,0 and 2 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 103502-48:
(8*1)+(7*0)+(6*3)+(5*5)+(4*0)+(3*2)+(2*4)+(1*8)=73
73 % 10 = 3
So 103502-48-3 is a valid CAS Registry Number.
103502-48-3Relevant articles and documents
COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION
-
, (2012/02/01)
Compositions and methods for inhibiting translation are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, (4) disorders associated with viral infections, and/or (5) non-proliferative metabolic disorders such as type II diabetes where inhibition of translation initiation is beneficial using the compounds disclosed herein.
Antiinflammation agents
-
, (2008/06/13)
Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic and cell proliferative conditions or diseases are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, metabolism and cell proliferation. The subject compounds contain fused carbocyclic or heterocyclic rings.
